Edge Rewrite
pun Source code View original
Jump to content

// Workers AI · dad joke modeWho's Clara Bonanad? A bone-a-fide star.

Add links
From Wikipedia, the free encyclopedia
Cardiologist Clara Bonanad
Clara Bonanad Speaker

Clara Bonanad Lozano is a Spanish cardiologist, cardiovascular researcher and associate professor. She is a research cardiologist at the INCLIVA Health Research Institute in Valencia and an associate professor in the Department of Medicine at the University of Valencia. Her clinical and scientific work focuses on geriatric cardiology, acute coronary syndromes, ischaemic heart disease, heart failure, cardiorenal disease, frailty, inflammation, immunothrombosis, residual cardiovascular risk and cardiac imaging.

Bonanad has held leadership roles in Spanish and Valencian cardiovascular societies, including president of the Geriatric Cardiology Section of the Spanish Society of Cardiology and president of the Ischaemic Heart Disease, ECG and Exercise Physiology Section of the Valencian Society of Cardiology. For the 2026-2028 term, she serves as vice-president for Valencia of the Valencian Society of Cardiology, and for the 2024-2026 term she is a member of the Clinical Cardiology Association of the Spanish Society of Cardiology.

Since 2013, Bonanad has delivered more than 300 scientific lectures at regional, national and international meetings, including conferences and educational activities held in Europe, Latin America, North America, the Middle East and Asia, both in person and online.

Education and training

[edit]

Bonanad graduated in Medicine and Surgery from the University of Valencia in 2007. She completed a doctoral programme in Preventive Medicine and Public Health at the same university and obtained her PhD in 2016 with the thesis Impacto Pronóstico de los Síndromes Geriátricos en Pacientes Ancianos con Síndrome Coronario Agudo, supervised by Juan Sanchís Forés and co-supervised by Vicente Ruiz. The thesis was awarded sobresaliente cum laude.

Her postgraduate training includes master's degrees and postgraduate programmes in acute cardiac care, cardiac imaging, advances in cardiology, clinical unit management and applications of artificial intelligence in healthcare. She has advanced competence in Catalan, English and French.


Research and career

[edit]

Bonanad completed her cardiology residency at the University Clinical Hospital of Valencia between 2008 and 2013. She subsequently worked as a specialist in cardiology, combining clinical practice with biomedical research. She held a Río Hortega postdoctoral contract from 2014 to 2016 and a Juan Rodés contract from 2022 to 2026.

At INCLIVA, Bonanad is linked to the Translational Research Group in Ischaemic Heart Disease and leads research activity in geriatric cardiology, immunothrombosis and cardiac rehabilitation. Her research has addressed frailty and geriatric syndromes in acute coronary syndromes, cardiac magnetic resonance after myocardial infarction, chronic coronary syndrome, heart failure, cardiorenal disease, hyperkalaemia, iron deficiency, inflammation and cardiovascular prevention.

She has also participated in national and international clinical trials and collaborative registries in heart failure, ischaemic heart disease, lipid disorders and cardiovascular risk. In addition, she was editor of the Spanish Heart Foundation Magazine from 2024 to 2025 and has participated in editorial activities for scientific journals including Journal of Clinical Medicine and Frontiers.

Areas of expertise

[edit]

Bonanad's areas of expertise include clinical cardiology, geriatric cardiology, cardiovascular research and the management of complex cardiovascular disease in older adults. Her work has focused on acute coronary syndromes, heart failure, atrial fibrillation, myocardial infarction, cardiovascular prevention, antithrombotic and anticoagulant therapy, cardiac amyloidosis, cardiovascular imaging and risk-factor control in patients with comorbidities such as diabetes, obesity, dyslipidaemia and frailty.

Her academic and translational research interests include immunothrombosis, lipidomics, biomarkers, cardiac rehabilitation after acute coronary syndrome and the early detection of cardiovascular disease.

Scientific societies and leadership roles

[edit]
  • Spanish Society of Cardiology: president of the Geriatric Cardiology Section for the 2019–2021 term.
  • Spanish Society of Cardiology: president-elect of the Clinical Cardiology Association for the 2024–2026 term.
  • Spanish Society of Cardiology: member of the Clinical Cardiology Association.
  • Spanish Society of Cardiology: member of the Women and Heart Committee from November 2023.
  • Valencian Society of Cardiology: president of the Ischaemic Heart Disease, ECG and Exercise Physiology Section.
  • Valencian Society of Cardiology: vice-president for Valencia for the 2026–2028 term.
  • Member of Spanish Society of Cardiology groups related to cardiopulmonary resuscitation, simulation, tutors and residents.

Publications

[edit]
  • Coronavirus: la emergencia geriátrica de 2020 |trans-title=Coronavirus: the geriatric emergency of 2020.[1]
  • CA125-guided diuretic treatment versus usual care in patients with acute heart failure and renal dysfunction. [2]
  • Frailty and hospitalization burden in patients with chronic heart failure. [3]
  • Effect of dapagliflozin on quality of life of patients with aortic stenosis undergoing transcatheter aortic valve implantation. [4]
  • Clinical predictors and prognosis of myocardial infarction with non-obstructive coronary arteries without ST-segment elevation in older adults. [5]
  • Sex-related differences in heart failure diagnosis. [6]
  • Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. [7]
  • Consensus document on palliative care in cardiorenal patients. [8]
  • Interdisciplinary recommendations for recurrent hyperkalaemia: insights from the GUARDIAN-HK European Steering Committee. [9]
  • Sex differences in the impact of frailty in elderly outpatients with heart failure.[10]
  • Infective Endocarditis in the Elderly: Challenges and Strategies.[11]
  • Cardiovascular prevention in elderly patients.[12]
  • Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes.[13]
  • Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome". [14]
  • Manual de bolsillo de diagnóstico y manejo de amiloidosis en el paciente mayor. [15]
  • Manual valoración geriátrica del paciente mayor con cardiopatía. [16]
  1. ↑ Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, Díez-Villanueva P, Ayesta A, Sanchis Forés J, Vidán-Austiz MT, Formiga F, Ariza-Solé A, Martínez-Sellés M (July 2020). "Coronavirus: la emergencia geriátrica de 2020" [Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology]. Revista Española de Cardiología (in Spanish). 73 (7): 569–576. doi:10.1016/j.recesp.2020.03.027. PMC 7129713. PMID 32292226.
  2. ↑ Núñez J, Llàcer P, García-Blas S, Bonanad C, Ventura S, Núñez JM, Sánchez R, Fácila L, de la Espriella R, Vaquer JM, Cordero A, Roqué M, Chamorro C, Bodí V, Valero E, Santas E, Moreno MD, Miñana G, Carratalá A, Rodríguez E, Mollar A, Palau P, Bosch MJ, Bertomeu-González V, Lupón J, Navarro J, Chorro FJ, Górriz JL, Sanchis J, Voors AA, Bayés-Genís A (March 2020). "CA125-guided diuretic treatment versus usual care in patients with acute heart failure and renal dysfunction". The American Journal of Medicine. 133 (3): 370–380.e4. doi:10.1016/j.amjmed.2019.07.041. hdl:11370/c5d71ab3-6bda-41db-8db9-91c0a4931aa9. PMID 31422111.
  3. ↑ Mollar A, Bonanad C, Díez-Villanueva P, Segarra D, Civera J, Sastre C, Conesa A, Villaescusa A, Fernández J, Miñana G, Navarro J, Sanchis J, Núñez J (15 November 2022). "Frailty and hospitalization burden in patients with chronic heart failure". The American Journal of Cardiology. 183: 48–54. doi:10.1016/j.amjcard.2022.08.013. PMID 36153181.
  4. ↑ Bonanad-Lozano C, García-Blas S, Amat-Santos I (October 2025). "Effect of dapagliflozin on quality of life of patients with aortic stenosis undergoing transcatheter aortic valve implantation". Journal of the American College of Cardiology. 86 (15): 1128–1138. doi:10.1016/j.jacc.2025.07.051. PMID 41062227.
  5. ↑ Gabaldón-Pérez A, Bonanad C, García-Blas S, Marcos-Garcés V, D'Gregorio JG, Fernández-Cisnal A, Valero E, Miñana G, Merenciano-González H, Mollar A, Bodí V, Núñez J, Sanchis J (2 February 2023). "Clinical predictors and prognosis of myocardial infarction with non-obstructive coronary arteries without ST-segment elevation in older adults". Journal of Clinical Medicine. 12 (3): 1181. doi:10.3390/jcm12031181. PMC 9918164. PMID 36769828.
  6. ↑ Maidana D, Bonanad C, Ortiz-Cortés C, Arroyo-Álvarez A, Barreres-Martín G, Muñoz-Alfonso C, Maicas-Alcaine E, García-Pérez C, Aparici-Redal A, Freitas-Durks V, Esteban-Fernández A (August 2023). "Sex-related differences in heart failure diagnosis". Current Heart Failure Reports. 20 (4): 254–262. doi:10.1007/s11897-023-00609-x. PMID 37310594.
  7. ↑ SEC Working Group for the 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice and SEC Guidelines Committee (May 2022). "Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice". Revista Española de Cardiología (in English and Spanish). 75 (5): 364–369. doi:10.1016/j.rec.2021.10.023. PMID 35165071.{{cite journal}}: CS1 maint: numeric names: authors list (link)
  8. ↑ Bonanad C, Buades JM, Leiva JP, de la Espriella R, Marcos MC, Núñez J, García-Llana H, Fácila L, Sánchez R, Rodríguez-Osorio L, Alonso-Babarro A, Quiroga B, Bompart Berroteran D, Rodríguez C, Maidana D, Díez J (19 December 2023). "Consensus document on palliative care in cardiorenal patients". Frontiers in Cardiovascular Medicine. 10 1225823. doi:10.3389/fcvm.2023.1225823. PMC 10766370. PMID 38179502.
  9. ↑ Savarese G, Izquierdo MJ, Bonanad C, Wong A, Schmitt R, Ferraro PM, Dentali F, Burton JO, Rosano G (4 November 2025). "Interdisciplinary recommendations for recurrent hyperkalaemia: insights from the GUARDIAN-HK European Steering Committee". European Heart Journal - Cardiovascular Pharmacotherapy. 11 (7): 630–637. doi:10.1093/ehjcvp/pvaf055. PMC 12582656. PMID 40685253.
  10. ↑ Díez-Villanueva, Pablo; Jiménez-Méndez, César; Bonanad, Clara; Ortiz-Cortés, Carolina; Barge-Caballero, Eduardo; Goirigolzarri, Josebe; Esteban-Fernández, Alberto; Pérez-Rivera, Angel; Cobo, Marta; Sanz-García, Ancor; Formiga, Francesc; Ariza-Solé, Albert; Martínez-Sellés, Manuel; Alfonso, Fernando (2022). "Sex differences in the impact of frailty in elderly outpatients with heart failure". Frontiers in Cardiovascular Medicine. 9 1000700. doi:10.3389/fcvm.2022.1000700. ISSN 2297-055X. PMC 9510708. PMID 36172583.
  11. ↑ Bea, Carlos; Vela, Sara; García-Blas, Sergio; Perez-Rivera, Jose-Angel; Díez-Villanueva, Pablo; de Gracia, Ana Isabel; Fuertes, Eladio; Oltra, Maria Rosa; Ferrer, Ana; Belmonte, Andreu; Santas, Enrique; Pellicer, Mauricio; Colomina, Javier; Doménech, Alberto; Bodi, Vicente (June 2022). "Infective Endocarditis in the Elderly: Challenges and Strategies". Journal of Cardiovascular Development and Disease. 9 (6): 192. doi:10.3390/jcdd9060192. ISSN 2308-3425. PMC 9224959. PMID 35735821.
  12. ↑ Bonanad, Clara; Fernández-Olmo, Rosa; García-Blas, Sergio; Alarcon, Jose Antonio; Díez-Villanueva, Pablo; Mansilla, Carmen Rus; García-Pardo, Héctor; Toledo, Pablo; Ayesta, Ana; Pereira, Eva; Carol, Antoni; Castro-Conde, Almudena; de Pablo-Zarzoso, Carmen; Martínez-Sellés, Manuel; Arrarte, Vicente (2022-05-28). "Cardiovascular prevention in elderly patients". Journal of Geriatric Cardiology. 19 (5): 377–392. doi:10.11909/j.issn.1671-5411.2022.05.004. ISSN 1671-5411. PMC 9170910. PMID 35722032.
  13. ↑ Bonanad, Clara; Esteve-Claramunt, Francisca; García-Blas, Sergio; Ayesta, Ana; Díez-Villanueva, Pablo; Pérez-Rivera, Jose-Ángel; Ferreiro, José Luis; Cánoves, Joaquim; López-Fornás, Francisco; Ariza Solé, Albert; Raposerias, Sergio; Vivas, David; Blanco, Regina; Bompart Berroterán, Daznia; Cordero, Alberto (January 2022). "Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes". Journal of Clinical Medicine. 11 (11): 3008. doi:10.3390/jcm11113008. ISSN 2077-0383. PMC 9181473. PMID 35683397.
  14. ↑ Bonanad, Clara; Raposeiras-Roubin, Sergio; García-Blas, Sergio; Núñez-Gil, Iván; Vergara-Uzcategui, Carlos; Díez-Villanueva, Pablo; Bañeras, Jordi; Badía Molins, Clara; Aboal, Jaime; Carreras, Jose; Bodi, Vicente; Gabaldón-Pérez, Ana; Mateus-Porta, Gemma; Parada Barcia, Jose Antonio; Martínez-Sellés, Manuel (January 2022). "Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome". Journal of Clinical Medicine. 11 (6): 1680. doi:10.3390/jcm11061680. ISSN 2077-0383. PMC 8955645. PMID 35330004.
  15. ↑ Lozano, Clara Bonanad (29 March 2023). Manual de bolsillo de diagnóstico y manejo de amiloidosis en el paciente mayor (in Spanish). Sociedad Española de Cardiología, Sección de Cardiología Geriátrica. ISBN 978-84-09-47248-2.
  16. ↑ Manual valoración geriátrica del paciente mayor con cardiopatía (in Spanish). Sociedad Española de Cardiología. 2020. Depósito legal: M-24487-2020.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Clara_Bonanad&oldid=1365095074"